Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,325,638 papers from all fields of science
Search
Sign In
Create Free Account
Hemorrhagic Fever, American
Known as:
American Hemorrhagic Fever
, Fever, American Hemorrhagic
, Hemorrhagic Fever, American [Disease/Finding]
Diseases caused by American hemorrhagic fever viruses (ARENAVIRUSES, NEW WORLD).
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Narrower (2)
Hemorrhagic Fever, Argentinian
Hemorrhagic Fever, Bolivian
In Blood
Microbiological
chemically induced
nursing therapy
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Factor VIII concentrate prepared from DDAVP stimulated blood donor plasma.
I. Nilsson
,
H. Walter
,
M. Mikaelsson
,
H. Vilhardt
Scandinavian Journal of Haematology
2009
Corpus ID: 41019600
Human fraction I-0 (AHF-Kabi) was prepared from plasma from blood donors who had received an i.v. injection of DDAVP (0.2…
Expand
1979
1979
Effects of Prolonged Room Temperature Holding of Whole Blood Intended for Preparation of Components
R. Kahn
,
Rebecca Lynn Johnson
,
W. Heaton
Transfusion
1979
Corpus ID: 30800492
Current FDA regulations require that platelet concentrates must be prepared within four hours of whole blood collection. To…
Expand
1979
1979
Surgery in von Willebrand's disease.
Inga MARIE NILSSON
,
Sven-Erik Bergentz
,
S. A. Larsson
Annals of Surgery
1979
Corpus ID: 35875241
Fifty-eight major surgical procedures were performed in 38 patients with von Willebrand's disease (VWD), one of the most common…
Expand
1976
1976
Management of Haemophilia in Sweden
I. Nilsson
Thrombosis and Haemostasis
1976
Corpus ID: 19645223
Summary The incidence of living haemophiliacs in Sweden (total population 8.1 millions) is about 1:15,000 males and about 1:30…
Expand
1975
1975
Heterogeneity of human circulating anticoagulants against antihemophilic factor (factor VIII).
M. Poon
,
A. Wine
,
O. Ratnoff
,
G. Bernier
Blood
1975
Corpus ID: 8362713
The heterogeneity of human circulating anticoagulants against antihemophilic factor (AHF, factor VIII) observed in seven patients…
Expand
1965
1965
ANTIBODY TO ANTIHEMOPHILIC FACTOR AND ITS LACK OF REACTION WITH HEMOPHILIC PLASMA.
W. McLester
,
R. Wagner
American Journal of Physiology
1965
Corpus ID: 36647711
A partially purified preparation of canine antihemophilic factor was obtained utilizing amino acids as precipitating agents. This…
Expand
Highly Cited
1964
Highly Cited
1964
PSYCHIATRIC STUDIES OF PATIENTS WITH HEMOPHILIA AND RELATED STATES.
D. Agle
Archives of Internal Medicine
1964
Corpus ID: 1582222
Classic hemophilia and Christmas disease are illnesses almost exclusively of males and are manifested primarily by bleeding into…
Expand
Highly Cited
1961
Highly Cited
1961
Treatment of classic hemophilia: the use of fibrinogen rich in factor VIII for hemorrhage and for surgery.
C. McMillan
,
L. Diamond
,
D. Surgenor
New England Journal of Medicine
1961
Corpus ID: 28583784
CLASSIC hemophilia, comprising about 80 per cent of the heritable coagulation disorders, is characterized by a hemostatic defect…
Expand
1958
1958
A circulation inhibitor (anti-AcG) specific for the labile factor-V of the blood-clotting mechanism.
J. Ferguson
,
C. L. Johnston
,
D. A. Howell
Blood
1958
Corpus ID: 5660301
Study of the present hemorrhagic disorder establishes, without doubt, the presence of a powerful specific anti-AcG. The…
Expand
1958
1958
Hemostatic data in relatives of hemophiliacs A and B; evidence for modifying the classical sex-linked recessive hypothesis.
P. Didisheim
,
J. Ferguson
,
J. Lewis
A M A Archives of Internal Medicine
1958
Corpus ID: 7270300
In 1803, Dr. John C. Otto,1of Philadelphia, reported observations on a familial hemorrhagic disorder affecting only males but…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE